SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-12-073528
Filing Date
2012-11-02
Accepted
2012-11-02 11:52:04
Documents
5
Group Members
ATLAS VENTURE ASSOCIATES VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a12-25948_1sc13d.htm SC 13D 87522
2 EX-1 a12-25948_1ex1.htm EX-1 13532
3 EX-2 a12-25948_1ex2.htm EX-2 105927
4 EX-3 a12-25948_1ex3.htm EX-3 174217
5 EX-4 a12-25948_1ex4.htm EX-4 171903
  Complete submission text file 0001104659-12-073528.txt   554771
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51477 | Film No.: 121175705
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 7816221700
Atlas Venture Fund VII L P (Filed by) CIK: 0001346450 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D